Disruption of the sodium-dependent citrate transporter SLC13A5 in mice causes alterations in brain citrate levels and neuronal network excitability in the hippocampus
In addition to tissues such as liver, the plasma membrane sodium-dependent citrate transporter, NaCT (SLC13A5), is highly expressed in brain neurons, but its function is not understood. Loss-of-function mutations in the human SLC13A5 gene have been associated with severe neonatal encephalopathy and...
Main Authors: | Christine Henke, Kathrin Töllner, R. Maarten van Dijk, Nina Miljanovic, Thekla Cordes, Friederike Twele, Sonja Bröer, Vanessa Ziesak, Marco Rohde, Stefanie M. Hauck, Charlotte Vogel, Lisa Welzel, Tina Schumann, Diana M. Willmes, Anica Kurzbach, Nermeen N. El-Agroudy, Stefan R. Bornstein, Susanne A. Schneider, Jens Jordan, Heidrun Potschka, Christian M. Metallo, Rüdiger Köhling, Andreas L. Birkenfeld, Wolfgang Löscher |
---|---|
Format: | Article |
Language: | English |
Published: |
Elsevier
2020-09-01
|
Series: | Neurobiology of Disease |
Subjects: | |
Online Access: | http://www.sciencedirect.com/science/article/pii/S096999612030293X |
Similar Items
-
Mapping the Metabolic Niche of Citrate Metabolism and <i>SLC13A5</i>
by: Fangfang Chen, et al.
Published: (2023-02-01) -
Growth and Overall Health of Patients with <i>SLC13A5</i> Citrate Transporter Disorder
by: Tanya L. Brown, et al.
Published: (2021-10-01) -
Characterizing a rare neurogenetic disease, SLC13A5 citrate transporter disorder, utilizing clinical data in a cloud-based medical record collection system
by: Emily M. Spelbrink, et al.
Published: (2023-03-01) -
Assessment of response of neoadjuvant chemotherapy in carcinoma breast patients by high-frequency ultrasound
by: Sajika Dighe, et al.
Published: (2022-01-01) -
A Study on Clinical and Pathological Responses to Neoadjuvant Chemotherapy in Breast Carcinoma
by: Kunnuru SKR, et al.
Published: (2020-11-01)